Cargando…

Cannabidiol in the acute phase of febrile infection‐related epilepsy syndrome (FIRES)

Febrile infection‐related epilepsy syndrome (FIRES) is a prolonged refractory status epilepticus (SE) that develops among healthy individuals after a febrile infection. FIRES treatment is challenging due to its poor response to antiseizure medications (ASMs) and anesthetic drugs. The use of cannabid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fetta, Anna, Crotti, Elisa, Campostrini, Elena, Bergonzini, Luca, Cesaroni, Carlo Alberto, Conti, Francesca, Di Pisa, Veronica, Gentile, Valentina, Mondardini, Maria Cristina, Vezzoli, Cesare, Giordano, Lucio, Cordelli, Duccio Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Short Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10235155/ https://www.ncbi.nlm.nih.gov/pubmed/37042946 http://dx.doi.org/10.1002/epi4.12740

Ejemplares similares

Status Epilepticus in Chromosomal Disorders Associated with Epilepsy: A Systematic Review
por: Bergonzini, Luca, et al.
Publicado: (2023)

Neurological Phenotype of Mowat-Wilson Syndrome
por: Cordelli, Duccio Maria, et al.
Publicado: (2021)

Cognitive, Behavioral, and Sensory Profile of Pallister–Killian Syndrome: A Prospective Study of 22 Individuals
por: Fetta, Anna, et al.
Publicado: (2022)

Sleep in Children With Pallister Killian Syndrome: A Prospective Clinical and Videopolysomnographic Study
por: Fetta, Anna, et al.
Publicado: (2021)

Hippocampal Changes in Febrile Infection-Related Epilepsy Syndrome (FIRES)
por: Agarwal, Amit, et al.
Publicado: (2015)

Claustrum sign in febrile infection-related epilepsy syndrome (FIRES)
por: Guo, Kundian, et al.
Publicado: (2023)

The Claustrum Sign in Febrile Infection-Related Epilepsy Syndrome (FIRES)
por: Di Dier, Kelly, et al.
Publicado: (2023)

Cannabidiol in the Treatment of Epilepsy
por: von Wrede, Randi, et al.
Publicado: (2021)

Febrile infection-related epilepsy syndrome (FIRES): prevalence, impact and management strategies
por: Serino, Domenico, et al.
Publicado: (2019)

Cannabidiol Treatment for Refractory Epilepsies in Pediatrics
por: Raucci, Umberto, et al.
Publicado: (2020)

Diminished toll-like receptor response in febrile infection-related epilepsy syndrome (FIRES)
por: Hsieh, Meng-Ying, et al.
Publicado: (2020)

Long-term outcomes of adult cryptogenic febrile infection–related epilepsy syndrome (FIRES)
por: Shi, Xiaojing, et al.
Publicado: (2023)

Cannabidiol as a treatment for epilepsy
por: Pickrell, William O., et al.
Publicado: (2017)

Cannabidiol in epilepsy: The indications and beyond
por: Ryan, Melody
Publicado: (2020)

Proposal to optimize evaluation and treatment of Febrile infection‐related epilepsy syndrome (FIRES): A Report from FIRES workshop
por: Koh, Sookyong, et al.
Publicado: (2021)

Targeted re-sequencing for early diagnosis of genetic causes of childhood epilepsy: the Italian experience from the ‘beyond epilepsy’ project
por: Amadori, Elisabetta, et al.
Publicado: (2020)

Relationship between Sensory Alterations and Repetitive Behaviours in Children with Autism Spectrum Disorders: A Parents’ Questionnaire Based Study
por: Fetta, Anna, et al.
Publicado: (2021)

Interleukin-6 Blockade With Tocilizumab in Anakinra-Refractory Febrile Infection-Related Epilepsy Syndrome (FIRES)
por: Stredny, Coral M., et al.
Publicado: (2020)

A case of febrile infection-related epilepsy syndrome (FIRES) in young adult: still a diagnostic and therapeutic challenge
por: Acampora, Roberto, et al.
Publicado: (2022)

Long-term neuropsychological outcomes in children with febrile infection-related epilepsy syndrome (FIRES) treated with anakinra
por: Shrestha, Anima, et al.
Publicado: (2023)

VNS in drug resistant epilepsy: preliminary report on a small group of patients
por: Franzoni, Emilio, et al.
Publicado: (2010)

Sleep disorders reveal distress among children and adolescents during the Covid-19 first wave: results of a large web-based Italian survey
por: Dondi, Arianna, et al.
Publicado: (2021)

Clinical and psychopathological profiles of children with somatic symptom disorders in a pediatric emergency unit: an observational study before and during the SARS-CoV-2 pandemic
por: Pruccoli, Jacopo, et al.
Publicado: (2023)

Cannabidiol and epilepsy in Brazil: a current review
por: Oshiro, Carlos André, et al.
Publicado: (2022)

Hemiplegic-Migraine–like Attacks as First Manifestation of Diffuse Leptomeningeal Glioneuronal Tumor: A Case Report
por: Fetta, Anna, et al.
Publicado: (2022)

Ketogenic diet (KD) therapy in the acute phase of febrile infection-related epilepsy syndrome (FIRES): a case report
por: Li, Wen-Jing, et al.
Publicado: (2021)

No evidence of neuronal/glial autoantibodies in febrile infection-related epilepsy syndrome (FIRES): a prospective clinic-serologic analysis
por: Soler Wenglein, Janina, et al.
Publicado: (2023)

Cannabidiol for epilepsy (Lennox-Gastaut syndrome, Dravet syndrome)
Publicado: (2020)

Post-Traumatic Headache in Children after Minor Head Trauma: Incidence, Phenotypes, and Risk Factors
por: Dondi, Arianna, et al.
Publicado: (2023)

Melatonin’s Effect in Febrile Seizures and Epilepsy
por: MAHYAR, Abolfazl, et al.
Publicado: (2014)

Aromatic L-Amino-Acid Decarboxylase Deficiency Screening by Analysis of 3-O-Methyldopa in Dried Blood Spots: Results of a Multicentric Study in Neurodevelopmental Disorders
por: Rizzi, Susanna, et al.
Publicado: (2023)

CELSR3 variants are associated with febrile seizures and epilepsy with antecedent febrile seizures
por: Li, Jia, et al.
Publicado: (2021)

Cannabidiol in Pharmacoresistant Epilepsy: Clinical Pharmacokinetic Data From an Expanded Access Program
por: Contin, Manuela, et al.
Publicado: (2021)

Use of Cannabidiol in the Treatment of Epilepsy: Efficacy and Security in Clinical Trials
por: Silvestro, Serena, et al.
Publicado: (2019)

Cannabidiol for Treatment of Childhood Epilepsy–A Cross-Sectional Survey
por: Klotz, Kerstin A., et al.
Publicado: (2018)

Cannabidiol in the Treatment of Epilepsy: A Focused Review of Evidence and Gaps
por: Silva, Guilherme Diogo, et al.
Publicado: (2020)

Efficacy and Tolerance of Synthetic Cannabidiol for Treatment of Drug Resistant Epilepsy
por: Klotz, Kerstin A., et al.
Publicado: (2019)

Pharmacogenetic Predictors of Cannabidiol Response and Tolerability in Treatment‐Resistant Epilepsy
por: Davis, Brittney H., et al.
Publicado: (2021)

Editorial: Cannabidiol Treatment in Neurotherapeutic Interventions
por: Gonzalez-Cuevas, Gustavo, et al.
Publicado: (2021)

Febrile infection-related Epilepsy Syndrome (FIRES): a severe encephalopathy with status epilepticus. Literature review and presentation of two new cases
por: Pavone, Piero, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qd85if51j970jo5st5liffs347